Novo Nordisk Cash on Hand 1988-2025 | NVO
Novo Nordisk cash on hand from 1988 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Novo Nordisk cash on hand for the quarter ending June 30, 2025 was $4.747B, a 47.49% decline year-over-year.
- Novo Nordisk cash on hand for 2024 was $4.732B, a 0.05% increase from 2023.
- Novo Nordisk cash on hand for 2023 was $4.73B, a 27% increase from 2022.
- Novo Nordisk cash on hand for 2022 was $3.724B, a 22.08% increase from 2021.
| Novo Nordisk Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $4,732 |
| 2023 | $4,730 |
| 2022 | $3,724 |
| 2021 | $3,051 |
| 2020 | $1,954 |
| 2019 | $2,348 |
| 2018 | $2,422 |
| 2017 | $3,214 |
| 2016 | $3,154 |
| 2015 | $3,090 |
| 2014 | $2,841 |
| 2013 | $2,848 |
| 2012 | $2,944 |
| 2011 | $3,271 |
| 2010 | $2,862 |
| 2009 | $2,402 |
| 2008 | |